56R1 Stock Chart & Stats
€6.75
--
Market closed
€6.75
--
Day’s Range― - ―
52-Week Range€6.05 - €8.70
Previous CloseN/A
VolumeN/A
Average Volume (3M)0.00
Market Cap
€2.77M
Enterprise Value-€255.97K
Total Cash (Recent Filing)€2.27M
Total Debt (Recent Filing)€1.21M
Price to Earnings (P/E)―
Beta0.65
Next EarningsN/A
EPS EstimateN/A
Next Dividend Ex-DateN/A
Dividend YieldN/A
Share Statistics
EPS (TTM)-6904.75
Shares Outstanding6,091,840
10 Day Avg. Volume0
30 Day Avg. Volume0
Financial Highlights & Ratios
PEG Ratio<0.01
Price to Book (P/B)0.06
Price to Sales (P/S)0.78
P/FCF Ratio-0.21
Enterprise Value/Market CapN/A
Enterprise Value/RevenueN/A
Enterprise Value/Gross ProfitN/A
Enterprise Value/EbitdaN/A
Forecast
1Y Price TargetN/A
Price Target UpsideN/A
Rating ConsensusN/A
Number of Analyst Covering0
EPS Forecast (FY)N/A
Revenue Forecast (FY)N/A
ENvue Medical Inc News
56R1 FAQ
What was ENvue Medical Inc’s price range in the past 12 months?
ENvue Medical Inc lowest stock price was €6.05 and its highest was €8.70 in the past 12 months.
What is ENvue Medical Inc’s market cap?
ENvue Medical Inc’s market cap is €2.77M.
When is ENvue Medical Inc’s upcoming earnings report date?
The company’s upcoming earnings report date is not yet available.
How were ENvue Medical Inc’s earnings last quarter?
ENvue Medical Inc released its earnings results on Nov 16, 2021. The company reported -€476.333 earnings per share for the quarter, missing the consensus estimate of N/A by -€476.333.
Is ENvue Medical Inc overvalued?
According to Wall Street analysts ENvue Medical Inc’s price is currently Overvalued.
Does ENvue Medical Inc pay dividends?
ENvue Medical Inc does not currently pay dividends.
What is ENvue Medical Inc’s EPS estimate?
ENvue Medical Inc’s EPS estimate for its next earnings report is not yet available.
How many shares outstanding does ENvue Medical Inc have?
ENvue Medical Inc has 6,091,840 shares outstanding.
What happened to ENvue Medical Inc’s price movement after its last earnings report?
ENvue Medical Inc reported an EPS of -€476.333 in its last earnings report, missing expectations of N/A. Following the earnings report the stock price went same N/A.
Which hedge fund is a major shareholder of ENvue Medical Inc?
Currently, no hedge funds are holding shares in DE:56R1
What is the TipRanks Smart Score and how is it calculated?
Smart Score combines eight research factors - such as analyst recommendations, hedge fund trends, and technical indicators - to measure a stock’s outlook. These signals are unified into a single score that reflects bullish or bearish momentum. See detailed methodology
Company Description
ENvue Medical Inc
NanoVibronix, Inc. focuses on developing non-surgical medical devices that stimulate biological responses. Its core offerings include UroShield and PainShield. The company's business activities span across several global markets, such as the United States, Europe, Australia, India, and Israel, in addition to other territories. This enterprise was founded by Harold Jacob and Jona Zumeris in September 2003, and its main corporate office is situated in Tyler, Texas.
Technical Analysis
Options Prices
Currently, No data available
---